Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

3.8K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.8K
Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

3.7K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.7K
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

4.5K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.5K
Hematopoiesis01:21

Hematopoiesis

8.4K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
8.4K
iPS Cell Differentiation01:22

iPS Cell Differentiation

3.0K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
3.0K
Overview of Hematopoiesis01:20

Overview of Hematopoiesis

8.0K
Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
8.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

ILC2s regulate a fibroblast progenitor niche in the pancreas.

Science (New York, N.Y.)·2026
Same author

Clonal Analyses Reveal the Impact of Hematopoietic Stem and Progenitor Cell Aging on T Cell Development.

Aging cell·2026
Same author

A kinetics-based model of haematopoiesis reveals extrinsic regulation of skewed lineage output from stem cells.

Nature cell biology·2026
Same author

Recurrent DNA break clusters drive replication-stress-induced copy number variants and genome diversification.

Nature communications·2026
Same author

Correction: Transient PU.1 low fetal progenitors generate lymphoid progeny that contribute to adult immunity.

Life science alliance·2025
Same author

Multipotent progenitors with distinct origins, clonal lineage fates, transcriptomes, and surface markers yield two hematopoietic trees.

Proceedings of the National Academy of Sciences of the United States of America·2025
Same journal

A guide to CAR T cell therapies: development, current status and future prospects.

Nature reviews. Immunology·2026
Same journal

Macrophages in embryonic development.

Nature reviews. Immunology·2026
Same journal

Glycolytic capacity instructs tumour vasculature and response to immunotherapy.

Nature reviews. Immunology·2026
Same journal

Vaginal NK cells limit epithelial barrier disruption during infection.

Nature reviews. Immunology·2026
Same journal

New insights into progenitor exhausted T cell populations.

Nature reviews. Immunology·2026
Same journal

T cell engagers in autoimmune diseases.

Nature reviews. Immunology·2026
See all related articles

Related Experiment Video

Updated: Jan 3, 2026

Isolation Method for Long-Term and Short-Term Hematopoietic Stem Cells
06:41

Isolation Method for Long-Term and Short-Term Hematopoietic Stem Cells

Published on: May 19, 2023

2.5K

Do haematopoietic stem cells age?

Kenneth Dorshkind1, Thomas Höfer2, Encarnacion Montecino-Rodriguez3

  • 1Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA. kdorshki@mednet.ucla.edu.

Nature Reviews. Immunology
|November 20, 2019
PubMed
Summary
This summary is machine-generated.

Ageing blood stem cells may not solely cause age-related blood production changes. Environmental factors and downstream progenitor alterations also contribute to altered haematopoiesis during ageing.

More Related Videos

Author Spotlight: Advancing Hematopoietic Research Using Stromal Cell Isolation for Single Cell Sequencing
05:27

Author Spotlight: Advancing Hematopoietic Research Using Stromal Cell Isolation for Single Cell Sequencing

Published on: January 26, 2024

1.5K
A Culture Method to Maintain Quiescent Human Hematopoietic Stem Cells
07:14

A Culture Method to Maintain Quiescent Human Hematopoietic Stem Cells

Published on: May 17, 2021

5.2K

Related Experiment Videos

Last Updated: Jan 3, 2026

Isolation Method for Long-Term and Short-Term Hematopoietic Stem Cells
06:41

Isolation Method for Long-Term and Short-Term Hematopoietic Stem Cells

Published on: May 19, 2023

2.5K
Author Spotlight: Advancing Hematopoietic Research Using Stromal Cell Isolation for Single Cell Sequencing
05:27

Author Spotlight: Advancing Hematopoietic Research Using Stromal Cell Isolation for Single Cell Sequencing

Published on: January 26, 2024

1.5K
A Culture Method to Maintain Quiescent Human Hematopoietic Stem Cells
07:14

A Culture Method to Maintain Quiescent Human Hematopoietic Stem Cells

Published on: May 17, 2021

5.2K

Area of Science:

  • Hematology
  • Stem Cell Biology
  • Gerontology

Background:

  • Accumulated genetic defects in hematopoietic stem cells (HSCs) are traditionally linked to age-related declines in lymphopoiesis and myeloid lineage skewing.
  • Transplantation studies using aged HSCs in young mice support an intrinsic HSC aging model.
  • This HSC-centric view may overlook crucial environmental influences on hematopoietic aging.

Purpose of the Study:

  • To challenge the prevailing HSC-centric model of hematopoietic aging.
  • To propose that environmental factors and changes in downstream progenitors contribute significantly to age-related changes in blood cell production.
  • To advocate for in situ analysis in unperturbed mice for a comprehensive understanding of aging hematopoiesis.

Main Methods:

  • Critically evaluating the limitations of traditional HSC transplantation models.
  • Proposing the analysis of blood cell production in unperturbed mice.
  • Utilizing in situ fate mapping techniques to study hematopoietic stem cells and their progeny in their native environment.

Main Results:

  • Evidence suggests that the traditional HSC transplantation model may lead to inaccurate conclusions about aging.
  • Age-related changes in hematopoietic stem cells and their microenvironment are implicated.
  • In situ fate mapping indicates that alterations in downstream progenitors, not solely HSC defects, contribute to reduced lymphopoiesis and myeloid skewing.

Conclusions:

  • The aging of the hematopoietic system is likely multifactorial, involving both intrinsic HSC changes and extrinsic environmental influences.
  • Downstream progenitor cell dynamics play a critical role in age-associated alterations in blood cell production.
  • Rethinking the experimental approaches is necessary for a complete understanding of hematopoietic aging, emphasizing in situ studies.